Literature DB >> 10759464

Montelukast and Churg-Strauss syndrome.

V Villena, R Hidalgo, M T Sotelo, P Martin-Escribano.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10759464     DOI: 10.1034/j.1399-3003.2000.15.33.x

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  6 in total

1.  Wegener's Granulomatosis after Treatment with Montelukast in a Patient not Receiving Systemic Corticosteroid Treatment.

Authors:  Aliye Candan Ogus; Aykut Cilli; Tulay Ozdemir; Gulay Ozbilim
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

Review 2.  Benefit-risk assessment of antileukotrienes in the management of asthma.

Authors:  Luis García-Marcos; Antje Schuster; Eduardo G Pérez-Yarza
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

3.  Montelukast-associated Churg-Strauss vasculitis: another associated report.

Authors:  Jonathan G Black; James R Bonner; Dennis Boulware; Aleodor A Andea
Journal:  Ann Allergy Asthma Immunol       Date:  2009-04       Impact factor: 6.347

4.  The linkage between Churg-Strauss syndrome and leukotriene receptor antagonists: fact or fiction?

Authors:  Deanna L McDanel; Barbara A Muller
Journal:  Ther Clin Risk Manag       Date:  2005-06       Impact factor: 2.423

5.  Churg-strauss syndrome in the pediatric age group.

Authors:  Yehia El-Gamal
Journal:  World Allergy Organ J       Date:  2008-02       Impact factor: 4.084

6.  Leukotriene Antagonists in Dermatology.

Authors:  Aditya Kumar Bubna
Journal:  Indian J Dermatol       Date:  2021 Sep-Oct       Impact factor: 1.494

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.